Valuation: Molecure S.A.

Market Cap 140M 36.18M 31.93M 30.21M 27.4M 51.37M 3.47B 51.88M 362M 1.77B 136M 133M 5.71B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 109M 28.18M 24.87M 23.53M 21.34M 40.01M 2.7B 40.4M 282M 1.38B 106M 104M 4.44B EV / Sales 2025
19.2x
EV / Sales 2026 * 69.3x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+0.89%
1 week-13.08%
Current month+11.15%
1 month+12.07%
3 months+24.63%
6 months+31.91%
Current year+2.73%
1 week 6.45
Extreme 6.45
7.82
1 month 5.95
Extreme 5.95
8.6
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.04
3 years 4.98
Extreme 4.98
22.5
5 years 4.98
Extreme 4.98
43.8
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 2012-11-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2023-01-02
Director TitleAgeSince
Director/Board Member - 2021-06-29
Chairman 38 2023-05-31
Director/Board Member - 2022-01-13
Date Insider Type Main position Quantity % Market Cap. Importance
12/22/23 Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-13.08%-8.75%-61.69% 36M
-0.70%-4.28%+52.62%+86.42% 71.81B
+0.45%-0.82%+38.81%+84.19% 60.06B
+4.49%+5.68%+36.16%+25.53% 27.93B
-1.73%-4.30%-18.37%+357.94% 25.7B
-0.51%-2.28%+0.48%-9.27% 24.89B
+0.65%+1.67%+26.47%-7.62% 20.92B
+3.46%+3.02%+158.90%+337.81% 15.04B
+0.48%+0.86%+44.56%+168.42% 14.46B
+4.74%+2.69%-3.50%+531.04% 13.87B
Average +1.22%-2.57%+32.74%+151.28% 27.47B
Weighted average by Cap. +0.65%-1.84%+37.13%+129.82%

Financials

2025 2026 *
Net sales 3.9M 1.01M 892K 844K 765K 1.43M 96.94M 1.45M 10.12M 49.5M 3.79M 3.71M 159M 2M 518K 457K 433K 392K 735K 49.71M 743K 5.19M 25.39M 1.95M 1.9M 81.69M
Net income -21.2M -5.49M -4.85M -4.59M -4.16M -7.8M -527M -7.87M -55.01M -269M -20.62M -20.17M -866M -13M -3.37M -2.97M -2.81M -2.55M -4.78M -323M -4.83M -33.73M -165M -12.64M -12.37M -531M
Net Debt -30.9M -8M -7.06M -6.68M -6.06M -11.36M -768M -11.48M -80.18M -392M -30.06M -29.4M -1.26B -1M -259K -229K -216K -196K -368K -24.86M -371K -2.59M -12.69M -973K -952K -40.85M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
26-09-29 PLN 6.780 +0.89% 81,615
26-09-28 PLN 6.720 -3.86% 84,335
26-09-25 PLN 6.990 -3.19% 117,058
26-09-24 PLN 7.220 -3.09% 62,335
26-09-23 PLN 7.450 -4.49% 42,932
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.780PLN
Average target price
12.45PLN
Spread / Average Target
+83.63%

Quarterly revenue - Rate of surprise